Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 230 member E (FAM230E), also known as LINC01662, is a human gene encoding a long intergenic non-protein coding RNA (lincRNA). LincRNAs are a subclass of long non-coding RNAs typically longer than 200 nucleotides and do not overlap protein-coding genes. They function in transcriptional regulation and chromatin architecture remodeling and are often involved in fine-tuning nearby gene expression, sometimes acting as enhancers or scaffolds for various complexes. While the general class of lincRNAs is increasingly associated with diverse biological functions and diseases, and even considered as potential biomarkers, the individual function of FAM230E remains unclear with limited direct research or validation in disease or therapeutics. Some database entries reference potential involvement with autism, but no mechanistic links have been established. FAM230E does not encode a protein target and is not considered a classical therapeutic target such as receptor or enzyme.
Null (no drug mechanism of action targeting this lincRNA)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 230 member E (FAM230E).